Lines of work

GP Pharm is developing different hormonal products based in peptides like Octreotide and others.

	Octreotide for Injection: This product is a pure generic formulation, based in a propietary buffer system (non patent infringent). A full CTD dossier including 3 years of stability data and a Bioequivalence study is available. Under registration in Spain.
	Vasopressin Analogues: GP Pharm is also working in the pharmaceutical development of vasopressin analogs. The routes of administration being considered are nasal sprays, solutions for injection and oral solutions.

See pipeline